# Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old

> **NCT07479394** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Hasanuddin University** · enrollment: 60 (estimated)

## Conditions studied

- Respiratory Tract Infections (RTI)

## Interventions

- **DIETARY_SUPPLEMENT:** a prebiotic, that us a standardized extract of cultured Lentinula edodes mycelia
- **DIETARY_SUPPLEMENT:** Placebo (dextrin)

## Key facts

- **NCT ID:** NCT07479394
- **Lead sponsor:** Hasanuddin University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07479394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07479394, "Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07479394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
